IL-4 and IL-10 modulate autoimmune haemolytic anaemia in NZB mice

Clinical and Experimental Immunology

Volumn 139, Issue 1, 2005, Pages 84-89

  Youssef, A R ^a   Shen, C R ^c   Lin, C L ^d   Barker, R N ^b   Elson, Chris J ^a,e  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d MING CHI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^e SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

Author keywords

Autoimmune haemolytic anaemia; IL 10; IL 4; NZB mice

Indexed keywords

AUTOANTIBODY; EPITOPE; FC RECEPTOR; FC RECEPTOR 2B2; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 4; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; GENE CONSTRUCT; HEMATOCRIT; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PLASMID; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL; TREATMENT OUTCOME; UPREGULATION;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANIMALS; ERYTHROCYTES; HEMATOCRIT; IMMUNOGLOBULIN G; INTERLEUKIN-10; INTERLEUKIN-4; MACROPHAGES; MICE; MICE, INBRED NZB; PLASMIDS; RECEPTORS, IGG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLEEN; UP-REGULATION;

EID: 11244302637     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02663.x     Document Type: Article

References (29)

1. Cua DJ, Hinton DR, Stohlman SA. Self-antigen induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice: Th2 mediated suppression of autoimmune disease. J Immunol 1995; 155:4052.
2. + Th2 cells specific for Mycobacterial 65-kilodalton heat shock protein protect against pristane-induced arthritis. J Immunol 1997; 159:3692-7.
3. Tisch R, Wanf B, Serreze DV. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J Immunol 1999; 163:1178-87.
4. Cameron MJ, Arreaza GA, Zucker P, Chensue SW, Strieter RM, Chakrabarti S, Delovitch TL. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol 1997; 159:4686-92.
5. Mueller R, Krahl T, Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 1996; 184:1093-9.
6. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role of interleukin-10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190:995-1004.
7. Burkhart C, Liu G, Anderton SM, Metzler B, Wraith DC. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol 1999; 11:1625-34.
8. Massey EJ, Sundstedt A, Day MJ, Corfield G, Anderton S, Wraith DC. Intranasal peptide-induced peripheral tolerance. the role of IL-10 in regulatory function within the context of experimental autoimmune encephalomyelitis. Vet Immunol Immunopthol 2002; 10:357-72.
9. Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA. Kuckroo VK. IL-10 is critical in the regulation of experimental autoimmune encephalomyelitis as demonstrated by studies in IL-10- and Il-4-deficient and transgenic mice. J Immunol 1998; 161:3299-306.
10. Segal BM, Dwyer BK, Shevach EM. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 1998; 187:537-46.
11. Persson S, Mikulowska A, Narula S, O'Garra A, Holmdahl R. Interleukin-10 suppresses the development of collagen type II arthritis in mice and ameliorates sustained arthritis in rats. Scand J Immunol 1996; 44:607-14.
12. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human interleukin-10 prevents the onset of diabetes in the nonobese diabetic (NOD) mouse. Clin Immunol Immunopathol 1994; 71:169-75.
13. Rott O, Fleischer B, Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 1994; 24:1434-40.
14. Barker RN, De Sa Oliveira GG, Elson CJ, Lydyard PM. Pathogenic autoantibodies in the NZB mouse are specific for erythrocyte band 3 protein. Eur J Immunol 1993; 23:1723-6.
15. Perry FE, Barker RN, Mazza G, Day MJ, Wells AD, Shen C-R, Schofield AE, Elson CJ. Autoreactive T cell specificity in autoimmune hemolytic anaemia of the NZB mouse. Eur J Immunol 1996; 26:136-41.
16. Shen CR, Wraith DC, Elson CJ. Splenic but not thymic autoreactive T cells from New Zealand black mice respond to a dominant erythrocyte band 3 peptide. Immunol 1999; 96:595-9.
17. Shen C-R, Ward FJ, Devine A, Luross JA, Lowery PA, Wraith DC, Elson CJ, Barker RN. Characterization of the dominant autoreactive T-cell epitope in spontaneous autoimmune haemolytic anaemia of the NZB mouse. J Autoimmunity 2002; 18:149-7.
18. Shen C-R, Youssef A-R, Devine A, Bowie L, Hall AM, Wraith DC, Elson CJ, Barker RN. Peptides containing a dominant T-cell epitope from red cell Band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune haemolytic anemia. Blood 2003; 102:3800-6.
19. Barker RN, Grufydd-Jones TJ, Stokes CR, Elson CJ. Autoimmune haemolysis in the dog. Relationship between anaemia and the level of red blood cell immunoglobulins and complement measured by an enzyme-linked antiglobulin test. Vet Imm Immunopath 1992; 34:1-20.
20. de Andres B, Rakasz E, Hagen M et al. Lack of Fc-epsilon receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood 1997; 89:3826-36.
21. Fossati-Jimack L, Ioan-Facsinay A, Rieninger L et al. Markedly different pathogenicity of four immunoglobin G isotpe-switch variants of an antierthyrocyte autoantibody is based on their capacity to interact in vivo with the low affinity Fcγ receptor 2. J Exp Med 2000; 191:1293-302.
22. Pricop L, Redecha P, Teillaud J-L, Frey J, Fridman WH, Sautes-Fridman WC, Salmon JE. Differential Modulation of stimulatory and inhibitory Fcγ receptors on human monocytes by Th1 and Th2 cytokines. J Immunol 2001; 166:531-7.
23. Tridandapani S, Siefker K, Teillaud J-L, Carter JE, Wewers MD, Anderson CL. Regulated expression and inhibitory function of FcγRIIb in human monocytic cells. J Biol Chem 2002; 277:5082-9.
24. Pritchard NR, Cutler AJ, Uribe S, Chadban SJ, Morley BJ, Smith KGC. Autoimmune-prone mice share a promotor haplotype associated with reduced expression and function of Fc receptor FcγRII. Current Biol 2000; 10:227-30.
25. Clatworthy MR, Smith KGC. FcγRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med 2004; 199:717-23.
26. Nisitani N, Tsubata T, Murakami M, Honjo T. Administration of interleukin-5 or -10 activates peritoneal B-1 cells and induced autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice. Eur J Immunol 1995; 25:3047-52.
27. Murakami M, Honjo T. Involvement of B-1 cells in mucosal immunity and autoimmunity. Imm Today 1995; 16:534-8.
28. id gene or generalised polyclonal B cell activation. J Immunol 1982; 128:2220-8.
29. Perez L, Orte J, Brieva JA. Terminal differentiation of spontaneous rheumatoid factor-secreting B cells from rheumatoid arthritis patients depends on endogenous interleukin-10. Arth Rheum 1995; 38:1771-6.